What are the best treatments for Parry-Romberg syndrome / Progressive hemifacial atrophy?

There is currently no cure for Parry-Romberg syndrome (also known as progressive hemifacial atrophy), so treatment focuses on managing symptoms and stabilizing disease progression through a combination of immunosuppressive therapy and reconstructive surgery. Because the condition varies significantly between individuals, management is highly personalized and typically requires a multidisciplinary medical team to address both the underlying inflammatory process and the resulting tissue atrophy.

What are the first-line treatments for Parry-Romberg syndrome?

In the active phase of Parry-Romberg syndrome, when tissue atrophy is progressing, physicians often prioritize stabilizing the immune system to halt the inflammatory process. While there is no standardized clinical protocol, many specialists utilize immunosuppressive medications to manage the condition. Commonly prescribed agents include methotrexate, prednisone, or mycophenolate mofetil (CellCept). These medications are typically used off-label based on clinical experience, as large-scale, randomized controlled trials are limited due to the rarity of the disease. Treatment effectiveness varies greatly; some patients see a stabilization of symptoms, while others may experience continued, albeit slower, progression.

What surgical and non-pharmacological options are available?

Once the disease process has stabilized—often after several years of slow progression—reconstructive surgery is the primary approach to correcting the cosmetic and functional deficits caused by Parry-Romberg syndrome. Because the condition involves the loss of fat, skin, and sometimes bone, surgical intervention is tailored to the severity of the atrophy. Common interventions include:

• Fat grafting (autologous fat transfer): Injecting the patient's own fat into the affected areas to restore volume.


• Dermal fillers: Often used for milder cases of atrophy to improve facial symmetry.


• Free flap reconstruction: In cases of severe atrophy, tissue may be transferred from other parts of the body (such as the abdomen or thigh) to provide substantial volume.


• Orthognathic surgery: If the atrophy has affected the underlying facial bones, specialized oral and maxillofacial surgeons may perform procedures to realign the jaw or augment the bone structure.

Which specialists should be on the care team?

Effective management of Parry-Romberg syndrome requires a collaborative, multidisciplinary approach. Patients should ideally be followed by a team that includes a rheumatologist (to manage inflammatory activity), a neurologist (to monitor associated symptoms like migraines or seizures), and a plastic or craniofacial surgeon (to plan for long-term reconstruction). At DiseaseMaps.org, our community of 106 individuals living with Parry-Romberg syndrome emphasizes the importance of early coordination between these specialists to ensure that both systemic health and aesthetic concerns are addressed.

What is the outlook for emerging research?

Research into Parry-Romberg syndrome is ongoing, with current efforts focusing on understanding the autoimmune mechanisms that trigger the atrophy. Some researchers are investigating the use of newer biologic therapies—which target specific components of the immune system—to see if they can more effectively halt the disease than traditional immunosuppressants. Clinical trials remain the best way to advance knowledge, and patients are encouraged to check registry databases for studies investigating progressive hemifacial atrophy.

Next steps

• Consult with a board-certified rheumatologist to discuss whether immunosuppressive therapy is appropriate for your current stage of disease.


• Seek a consultation with a craniofacial plastic surgeon who has specific experience with hemifacial atrophy to discuss long-term reconstructive planning.


• Monitor for neurological symptoms, such as new-onset seizures or chronic headaches, and report these to your neurologist immediately.


• Connect with the 106 members of the Parry-Romberg syndrome community on DiseaseMaps.org to share experiences and learn about regional specialist recommendations.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult with your personal healthcare team regarding your specific diagnosis and treatment plan.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Progressive Hemifacial Atrophy.


• Orphanet: Parry-Romberg Syndrome (ORPHA:2803).


• OMIM (Online Mendelian Inheritance in Man): Parry-Romberg Syndrome (Entry #141300).


• The American Society of Plastic Surgeons: Resources on Craniofacial Reconstruction.